Page 85 - Read Online

Song et al. Hepatoma Res 2020;6:27 I http://dx.doi.org/10.20517/2394-5079.2020.05 Page 13 of 15

67. Namjou B, Lingren T, Huang Y, Parameswaran S, Cobb BL, et al. GWAS and enrichment analyses of non-alcoholic fatty liver disease
identify new trait-associated genes and pathways across eMERGE Network. BMC Med 2019;17:135.
68. Grimaudo S, Pipitone RM, Pennisi G, Celsa C, Camma C, et al. Association between PNPLA3 rs738409 C>G variant and liver-related
outcomes in patients with non-alcoholic fatty liver disease. Clin Gastroenterol Hepatol 2020;18:935-44.e3.
69. Tepper CG, Dang JHT, Stewart SL, Fang DM, Wong KA, et al. High frequency of the PNPLA3 rs738409 [G] single-nucleotide
polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease. Cancer 2018;124:1583-9.
70. Petta S, Valenti L, Tuttolomondo A, Dongiovanni P, Pipitone RM, et al. Interferon lambda 4 rs368234815 TT>deltaG variant is
associated with liver damage in patients with nonalcoholic fatty liver disease. Hepatology 2017;66:1885-93.
71. Petta S, Valenti L, Svegliati-Baroni G, Ruscica M, Pipitone RM, et al. Fibronectin type III domain-containing protein 5 rs3480 A>G
polymorphism, irisin, and liver fibrosis in patients with nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2017;102:2660-9.
72. Cheng YW, Chen KW, Kuo HC, Kuo CH, Lin WH, et al. Specific diacylglycerols generated by hepatic lipogenesis stimulate the
oncogenic androgen receptor activity in male hepatocytes. Int J Obes (Lond) 2019;43:2469-79.
73. Campisano S, La Colla A, Echarte SM, Chisari AN. Interplay between early-life malnutrition, epigenetic modulation of the immune
function and liver diseases. Nutr Res Rev 2019;32:128-45.
74. Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev
Cancer 2012;12:298-306.
75. Yan W, Liu X, Ma H, Zhang H, Song X, et al. Tim-3 fosters HCC development by enhancing TGF-beta-mediated alternative activation
of macrophages. Gut 2015;64:1593-604.
76. Faure-Dupuy S, Delphin M, Aillot L, Dimier L, Lebosse F, et al. Hepatitis B virus-induced modulation of liver macrophage function
promotes hepatocyte infection. J Hepatol 2019;71:1086-98.
77. Bility MT, Cheng L, Zhang Z, Luan Y, Li F, et al. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model:
induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog 2014;10:e1004032.
78. Cheng X, Xia Y, Serti E, Block PD, Chung M, et al. Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine
production by macrophages. Hepatology 2017;66:1779-93.
79. Tian Y, Kuo CF, Akbari O, Ou JH. Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral
persistence after vertical transmission. Immunity 2016;44:1204-14.
80. Chen J, Xu W, Chen Y, Xie X, Zhang Y, et al. Matrix metalloproteinase 9 facilitates hepatitis B virus replication through binding with
type i interferon (IFN) receptor 1 to repress IFN/JAK/STAT signaling. J Virol 2017;91.
81. Zang M, Li Y, He H, Ding H, Chen K, et al. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes
hepatocellular carcinoma development after chronic hepatitis B virus infection. Biochim Biophys Acta Mol Basis Dis 2018;1864:3759-70.
82. de Oliveira S, Houseright RA, Graves AL, Golenberg N, Korte BG, et al. Metformin modulates innate immune-mediated inflammation
and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish. J Hepatol 2019;70:710-21.
83. Malehmir M, Pfister D, Gallage S, Szydlowska M, Inverso D, et al. Platelet GPIbalpha is a mediator and potential interventional target
for NASH and subsequent liver cancer. Nat Med 2019;25:641-55.
84. Eckert C, Klein N, Kornek M, Lukacs-Kornek V. The complex myeloid network of the liver with diverse functional capacity at steady
state and in inflammation. Front Immunol 2015;6:179.
85. Walenbergh SM, Houben T, Hendrikx T, Jeurissen ML, van Gorp PJ, et al. Weekly treatment of 2-hydroxypropyl-beta-cyclodextrin
improves intracellular cholesterol levels in LDL receptor knockout mice. Int J Mol Sci 2015;16:21056-69.
86. Leroux A, Ferrere G, Godie V, Cailleux F, Renoud ML, et al. Toxic lipids stored by Kupffer cells correlates with their pro-
inflammatory phenotype at an early stage of steatohepatitis. J Hepatol 2012;57:141-9.
87. Alisi A, Carpino G, Oliveira FL, Panera N, Nobili V, et al. The role of tissue macrophage-mediated inflammation on NAFLD
pathogenesis and its clinical implications. Mediators Inflamm 2017;2017:8162421.
88. Liu XL, Pan Q, Cao HX, Xin FZ, Zhao ZH, et al. Lipotoxic hepatocyte-derived exosomal mir-192-5p activates macrophages via
Rictor/Akt/FoxO1 signaling in NAFLD. Hepatology 2019; Epub ahead of print. doi: 10.1002/hep.31050
89. Luo X, Li H, Ma L, Zhou J, Guo X, et al. Expression of STING is increased in liver tissues from patients with NAFLD and promotes
macrophage-mediated hepatic inflammation and fibrosis in mice. Gastroenterology 2018;155:1971-84.e4.
90. Yang F, Yu X, Zhou C, Mao R, Zhu M, et al. Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor
cells to dampen T-cell function in chronic hepatitis B virus infection. PLoS Pathog 2019;15:e1007690.
91. Fang Z, Li J, Yu X, Zhang D, Ren G, et al. Polarization of monocytic myeloid-derived suppressor cells by hepatitis b surface antigen
is mediated via ERK/IL-6/STAT3 signaling feedback and restrains the activation of T cells in chronic hepatitis B virus infection. J
Immunol 2015;195:4873-83.
92. Yu Z, Gao YQ, Feng H, Lee YY, Li MS, et al. Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-
associated hepatocarcinogenesis. Gut 2014;63:1793-804.
93. Zhou J, Liu M, Sun H, Feng Y, Xu L, et al. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell
immunosuppression and enhances immune-checkpoint blockade efficacy. Gut 2018;67:931-44.
94. Sun H, Yang W, Tian Y, Zeng X, Zhou J, et al. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and
immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma. Nat Commun 2018;9:5214.
95. Tsunashima H, Tsuneyama K, Moritoki Y, Hara M, Kikuchi K. Accumulated myeloid-derived suppressor cells demonstrate distinct
phenotypes and functions in two non-alcoholic steatohepatitis mouse models. Hepatobiliary Surg Nutr 2015;4:313-9.
96. Yao L, Abe M, Kawasaki K, Akbar SM, Matsuura B, et al. Characterization of liver monocytic myeloid-derived suppressor cells and
their role in a murine model of non-alcoholic fatty liver disease. PLoS One 2016;11:e0149948.
97. Pallmer K, Oxenius A. Recognition and regulation of T cells by NK cells. Front Immunol 2016;7:251.
98. Biron CA, Altfeld M. Is there natural killer cell memory and can it be harnessed by vaccination? Can natural killer and CD8 T cells